Advertisement

Reactions Weekly

, Volume 1737, Issue 1, pp 189–189 | Cite as

Lutetium-(177Lu)-oxodotreotide/yttrium-90-DOTATOC

Kidney toxicity: case report
Case report
  • 11 Downloads

Reference

  1. Vitali S, et al. Feasibility of a combination of 90Y/177Lu-Radiopeptide Therapy (Peptide Receptor Radionuclide Therapy - PRRT) and External Beam Radiation Therapy (EBRT) in neuroendocrine tumors (NETs). Physica Medica 56 (Suppl. 2): 259-260, Dec 2018. Available from: URL: http://doi.org/10.1016/j.ejmp.2018.04.334 [abstract] - Italy

Copyright information

© Springer Nature Switzerland AG 2019

Personalised recommendations